Albumin-granulocyte colony stimulating factor (Beijing BioFortune/Tianjin SinoBiotech)

重组人血清白蛋白/粒细胞刺激因子融合蛋白

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAlbumin-granulocyte colony stimulating factor (Beijing BioFortune/Tianjin SinoBiotech)
Drug Alias NameHSA-GCSFrHSA/GCSF fusion protein (Tianjin SinoBiotech)Albumin fusion protein (Tianjin)Human Serum Albumin GCSFSFR-9314 +[6] 
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsChemotherapy-Induced Febrile NeutropeniaNeutropeniaAgranulocytosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesTianjin Puying Biotechnology Co LtdBeijing Meifuyuan Biomedical Technology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesFortunerock IncTianjin Puying Biotechnology Co LtdBeijing Meifuyuan Biomedical Technology Co Ltd +[4] 
Inactive CompaniesTianjin Sinobiotech Ltd
Active IndicationsChemotherapy-Induced Febrile Neutropenia
Inactive IndicationsNeutropeniaAgranulocytosis

Other Information

ATC CodeN/A
Related LinksN/A